111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Revenue (Most Recent Fiscal Year) | $2.11B |
Net Income (Most Recent Fiscal Year) | $-43.07M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 0.04 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -2.36% |
Net Margin (Trailing 12 Months) | -2.62% |
Return on Equity (Trailing 12 Months) | -- |
Return on Assets (Trailing 12 Months) | -12.29% |
Current Ratio (Most Recent Fiscal Quarter) | 1.06 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.55 |
Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
Inventory Turnover (Trailing 12 Months) | 9.83 |
Book Value per Share (Most Recent Fiscal Quarter) | $-1.00 |
Earnings per Share (Most Recent Fiscal Quarter) | -- |
Earnings per Share (Most Recent Fiscal Year) | -- |
Diluted Earnings per Share (Trailing 12 Months) | $-0.66 |
Exchange | NASDAQ |
Sector | Consumer Defensive |
Industry | Pharmaceutical Retailers |
Common Shares Outstanding | 83.52M |
Free Float | 46.85M |
Market Capitalization | $85.19M |
Average Volume (Last 20 Days) | 0.06M |
Beta (Past 60 Months) | 0.38 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 43.90% |
Percentage Held By Institutions (Latest 13F Reports) | 21.32% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |